Skip to main content
Top
Published in: Pediatric Cardiology 6/2017

Open Access 01-08-2017 | Original Article

Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death

Authors: Eva Fernlund, A. Wålinder Österberg, E. Kuchinskaya, M. Gustafsson, K. Jansson, C. Gunnarsson

Published in: Pediatric Cardiology | Issue 6/2017

Login to get access

Abstract

Familial dilated cardiomyopathy is a rare cause of dilated cardiomyopathy (DCM), especially in childhood. Our aim was to describe the clinical course and the genetic variants in a family where the proband was a four-month-old infant presenting with respiratory problems due to DCM. In the family, there was a strong family history of DCM and sudden cardiac death in four generations. DNA was analyzed initially from the deceased girl using next-generation sequencing including 50 genes involved in cardiomyopathy. A cascade family screening was performed in the family after identification of the TNNT2 and the BAG3 variants in the proband. The first-degree relatives underwent clinical examination including biochemistry panel, cardiac ultrasound, Holter ECG, exercise stress test, and targeted genetic testing. The index patient presented with advanced DCM. After a severe clinical course, the baby had external left ventricular assist as a bridge to heart transplantation. 1.5 months after transplantation, the baby suffered sudden cardiac death (SCD) despite maximal treatment in the pediatric intensive care unit. The patient was shown to carry two heterozygous genetic variants in the TNNT2 gene [TNNT2 c.518G>A(p.Arg173Gln)] and BAG3 [BAG3 c.785C>T(p.Ala262Val)]. Two of the screened individuals (two females) appeared to carry both the familial variants. All the individuals carrying the TNNT2 variant presented with DCM, the two adult patients had mild or moderate symptoms of heart failure and reported palpitations but no syncope or presyncopal attacks prior to the genetic diagnosis. The female carriers of TNNT2 and BAG3 variants had more advanced DCM. In the family history, there were three additional cases of SCD due to DCM, diagnosed by autopsy, but no genetic analysis was possible in these cases. Our findings suggest that the variants in TNNT2 and BAG3 are associated with a high propensity to life-threatening cardiomyopathy presenting from childhood and young adulthood.
Literature
1.
go back to reference Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733–2779CrossRefPubMed Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733–2779CrossRefPubMed
2.
go back to reference Wilkinson JD, Landy DC, Colan SD et al (2010) The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 6(4):401–413CrossRefPubMedPubMedCentral Wilkinson JD, Landy DC, Colan SD et al (2010) The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 6(4):401–413CrossRefPubMedPubMedCentral
3.
go back to reference Kirk R, Dipchand AI, Rosenthal DN et al (2014) The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. [Corrected]. J Heart Lung Transplant 33(9):888–909CrossRefPubMed Kirk R, Dipchand AI, Rosenthal DN et al (2014) The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. [Corrected]. J Heart Lung Transplant 33(9):888–909CrossRefPubMed
6.
go back to reference Pettersen MD, Du W, Skeens ME, Humes RA (2008) Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 21(8):922–934CrossRefPubMed Pettersen MD, Du W, Skeens ME, Humes RA (2008) Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 21(8):922–934CrossRefPubMed
7.
go back to reference Nugent AW, Daubeney PE, Chondros P et al (2003) The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348(17):1639–1646CrossRefPubMed Nugent AW, Daubeney PE, Chondros P et al (2003) The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348(17):1639–1646CrossRefPubMed
8.
go back to reference Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655CrossRefPubMed Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655CrossRefPubMed
10.
go back to reference Mestroni L, Rocco C, Gregori D et al (1999) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34(1):181–190CrossRefPubMed Mestroni L, Rocco C, Gregori D et al (1999) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34(1):181–190CrossRefPubMed
11.
go back to reference Hershberger RE, Cowan J, Morales A, Siegfried JD (2009) Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2(3):253–261CrossRefPubMedPubMedCentral Hershberger RE, Cowan J, Morales A, Siegfried JD (2009) Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2(3):253–261CrossRefPubMedPubMedCentral
12.
go back to reference Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13(8):1077–1109CrossRefPubMed Ackerman MJ, Priori SG, Willems S et al (2011) HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 13(8):1077–1109CrossRefPubMed
14.
go back to reference Luedde M, Ehlermann P, Weichenhan D et al (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86(3):452–460CrossRefPubMed Luedde M, Ehlermann P, Weichenhan D et al (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovasc Res 86(3):452–460CrossRefPubMed
15.
go back to reference Jachymova M, Muravska A, Palecek T et al (2012) Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy. Physiol Res 61(2):169–175PubMed Jachymova M, Muravska A, Palecek T et al (2012) Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy. Physiol Res 61(2):169–175PubMed
16.
go back to reference Van Acker H, De Sutter J, Vandekerckhove K, de Ravel TJ, Verhaaren H, De Backer J (2010) Dilated cardiomyopathy caused by a novel TNNT2 mutation-added value of genetic testing in the correct identification of affected subjects. Int J Cardiol 144(2):307–309CrossRefPubMed Van Acker H, De Sutter J, Vandekerckhove K, de Ravel TJ, Verhaaren H, De Backer J (2010) Dilated cardiomyopathy caused by a novel TNNT2 mutation-added value of genetic testing in the correct identification of affected subjects. Int J Cardiol 144(2):307–309CrossRefPubMed
17.
go back to reference Hernandez Del Rincon et al (2011) Unpublished data, Poster Presentation, 19th International Association of Forensic Sciences World Meeting, Spain Hernandez Del Rincon et al (2011) Unpublished data, Poster Presentation, 19th International Association of Forensic Sciences World Meeting, Spain
18.
go back to reference Norton N, Li D, Rieder MJ et al (2011) Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 88(3):273–282CrossRefPubMedPubMedCentral Norton N, Li D, Rieder MJ et al (2011) Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 88(3):273–282CrossRefPubMedPubMedCentral
Metadata
Title
Novel Genetic Variants in BAG3 and TNNT2 in a Swedish Family with a History of Dilated Cardiomyopathy and Sudden Cardiac Death
Authors
Eva Fernlund
A. Wålinder Österberg
E. Kuchinskaya
M. Gustafsson
K. Jansson
C. Gunnarsson
Publication date
01-08-2017
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 6/2017
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1655-0

Other articles of this Issue 6/2017

Pediatric Cardiology 6/2017 Go to the issue